CUSIP: 372427401
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,403,397
-
Share change
-
+7,403,397
-
Total reported value
-
$29,025,250
-
Put/Call ratio
-
5.2%
-
Price per share
-
$3.92
-
Number of holders
-
37
-
Value change
-
+$29,025,250
-
Number of buys
-
37
Quarterly Holders Quick Answers
What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 372427401:
Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q2 2019
As of 30 Jun 2019,
GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,403,397 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, DAFNA Capital Management LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Vivo Capital, LLC, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., Endurant Capital Management LP, Polaris Venture Management Co. V, L.L.C., and MILLENNIUM MANAGEMENT LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.